A protein kinase C-β-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats

Diabetes

Volumn 48, Issue 10, 1999, Pages 2090-2095

  Nakamura, Jiro ^a   Kato, Koichi ^a   Hamada, Yoji ^a   Nakayama, Mikihiro ^a   Chaya, Sadao ^a   Nakashima, Eitaro ^a   Naruse, Keiko ^a   Kasuya, Yasuhide ^a   Mizubayashi, Ryuichi ^a   Miwa, Kazuma ^a   Yasuda, Yutaka ^a   Kamiya, Hideki ^a   Ienaga, Kazuharu ^a   Sakakibara, Fumihiko ^a   Koh, Naoki ^a   Hotta, Nigishi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; INOSITOL; NZ 314; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ELECTRORETINOGRAM; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MOTOR NERVE CONDUCTION; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ALDEHYDE REDUCTASE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FRUCTOSE; INDOLES; ISOENZYMES; MALE; MALEIMIDES; MOTOR NEURONS; NEURAL CONDUCTION; PROTEIN KINASE C; PYRIMIDINONES; RATS; RATS, WISTAR; SCIATIC NERVE; SORBITOL; THIAZOLES;

EID: 0032836509     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.10.2090     Document Type: Article

References (48)

1. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA: Complication: neuropathy, pathogenic considerations. Diabetes Care 15:1902-1925, 1992
2. Hotta N, Sakamoto N: Aldose reductase inhibitors. In The Diabetes Annual/5. Alberti KGMM, Krall LP, Eds. Amsterdam, Elsevier, 1990, p. 330-361
3. Tomlinson DR, Willars GB, Carrington AL: Aldose reductase inhibitors and diabetic complications. Pharmacol Ther 54:151-194, 1992
4. Greene DA, Lattimer-Greene SA, Sima AAF: Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. Crit Rev Neurobiol 5:143-219, 1989
5. Zhu X, Eichberg J: 1,2-Diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J Neurochem 55:1087-1090, 1990
6. Nakamura J, Del Monte MA, Shewach D, Lattimer SA, Greene DA: Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells. Am J Physiol 262:E417-E426, 1992
7. Thomas TP, Feldman EL, Nakamura J, Kato K, Lien K, Stevens MJ, Greene DA: Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture. Proc Natl Acad Sci U S A 90:9712-9716, 1993
8. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
9. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A 89:11059-11063, 1992
10. Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener EP, King GL: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 267:E369-E379, 1994
11. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clemount A, Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunction in diabetic rats by an oral PKC β inhibitor. Science 272:728-731, 1996
12. Koya D, Jirousek MR, Lin Y-W, Ishii H, Kuboki K, King GL: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
13. Tesfaye S, Malik R, Ward JD: Vascular factors in diabetic neuropathy. Diabetologia 37:847-854, 1994
14. Cameron NE, Cotter MA: Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 46 (Suppl. 2):S31-S37, 1997
15. Cameron NE, Cotter MA: The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 10:189-224, 1994
16. Maxfield EK, Love A, Cotter MA, Cameron NE: Nerve function and regeneration in diabetic rats: effects of ZD-7155, an ATI receptor antagonist. Am J Physiol 269:E530-E537, 1995
17. Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Hara T, Mori K, Nakashima E, Naruse K, Fukasawa H, Kakuta H, Sakamoto N: Effects of beraprost sodium and insulin on the electroretinogram, nerve conduction, and nerve blood flow in rats with streptozotocin-induced diabetes. Diabetes 45:361-366, 1996
18. Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K, Naruse K, Nakashima E, Fukasawa H, Kakuta H: Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats. Prostaglandins 49:339-349, 1995
19. Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Hara T, Mori K, Naruse K, Fukasawa H, Kakuta H, Sakamoto N: Nerve function and blood flow in Otsuka Long-Evans Tokushima Fatty rats with sucrose feeding: effect of an anticoagulant. Eur J Pharmacol 313:201-209, 1996
20. Shimamoto Y, Shimamoto H, Kwan C, Daniel EE: Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am J Physiol 264:H1300-H1306, 1993
21. Cohen RA: Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 (Suppl. V):67-76, 1993
22. Ishii A, Kotani T, Nagaki Y, Shibayama Y, Toyomaki Y, Okukado N, Ienaga K, Okamoto K: Highly selective aldose reductase inhibitors. 1. 3-(arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic acids. J Med Chem 39:1924-1927, 1996
23. Miyoshi T, Goto I: Serial in vivo determinations of nerve conduction velocity in rat tail: physiological and pathological changes. Electroencephalogr Clin Neurophysiol 35:125-131, 1973
24. Nakamura J, Koh N, Sakakibara F, Hamada Y, Hara T, Sasaki H, Chaya S, Komori T, Nakashima E, Naruse K, Kato K, Takeuchi N, Kasuya Y, Hotta N: Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats. J Pharmacol Exp Ther 287:897-902, 1998
25. Koshu K, Kamiyama K, Oka S, Takaku A, Saito T: Measurement of regional blood flow using hydrogen gas generated by electrolysis. Stroke 13:483-487, 1982
26. Segawa M, Hirata Y, Fujimori S, Okada Y: The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia. Metabolism 37:454-460, 1988
27. Hotta N, Nakamura J, Sakakibara F, Hamada Y, Hara T, Mori K, Nakashima E, Sasaki H, Kasama N, Inukai S, Koh N: Electroretinogram in sucrose-fed diabetic rats treated with an aldose reductase inhibitor or an anticoagulant. Am J Physiol 273:E965-E971, 1997
28. Mizuno K, Kato N, Matsubara A, Nakano K, Kurono M: Effects of a new aldose reductase inhibitor, (2S, 4S:)-6-fluoro 2′,5′-dioxospiro [chroman-4,4′-imidazolidinine]-2-carboxamide (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Metabolism 41:1081-1086, 1992
29. Nakamura J, Koh N, Sakakibara F, Hamada Y, Wakao T, Sasaki H, Mori K, Nakashima E, Naruse K, Hotta N: Diabetic neuropathy in sucrose-fed Otsuka Long-Evans Tokushima fatty rats: effect of an aldose reductase inhibitor, TAT. Life Sci 60:1847-1857, 1997
30. Cameron NE, Cotter MA, Dines KC, Hohman TC: Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509 in streptozotocin-induced diabetic rats. J Diabetes Complications 10:43-53, 1996
31. Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K, Naruse K, Nakashima E, Inukai S, Sakamoto N: Effect of a potent new aldose reductase inhibitor, (5-(3-thienyl)tetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats. Diabetes Res Clin Pract 27: 107-117, 1995
32. Yasuda H, Sonobe M, Yamashita M, Terada M, Hatanaka I, Huitian Z, Shigeta Y: Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats: comparison with aldose reductase inhibitor ONO 2235. Diabetes 38:832-838, 1989
33. Kim J, Rushovich EH, Thomas TP, Ueda T, Agranoff BW, Greene DA: Diminished specific activity of cytosolic protein kinase C in sciatic nerves of streptozocin-induced diabetic rats and its correction by dietary myo-inositol. Diabetes 40:1545-1554, 1991
34. Mathew J, Bianchi R, Mclean WG, Peterson RG, Roberts RE, Savaresi S, Eichberg J: Phosphoinositide metabolism: Na,K-ATPase and protein kinase C are altered in peripheral nerve from Zucker diabetic fatty rats (ZDF/Gmi-fa). Neurosci Res Commun 20:21-30, 1997
35. Kowluru RA, Jirousek MR, Stramm L, Farid N, Engerman RL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes 47:464-469, 1998
36. Borghini I, Ania-Lahuerta A, Regazzi R, Ferrari G, Gjinovci A, Wollheim CB, Pralong WF: α, βI, βII, δ, and ε protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats. J Neurochem 62:686-696, 1994
37. Roberts RE, McLean WG: Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Res 754: 147-156, 1997
38. Kim J, Kyriazi H, Greene DA: Normalization of Na,K-ATPase activity in isolated membrane fraction from sciatic nerves of streptozotocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonist in vitro. Diabetes 40:558-567, 1991
39. Hermenegildo C, Felipo V, Minana M-D, Grisolia S: Inhibition of protein kinase C restores Na+,K+-ATPase activity in sciatic nerve of diabetic mice. J Neurochem 58:1246-1249, 1992
40. +-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitor of PKC. Diabetes 42:257-262, 1993
41. Dines KC, Cotter MA, Cameron NE: Nerve function in galactosemic rats: effects of evening primrose oil and doxazosin. Eur J Pharmacol 281:303-309, 1995
42. Love A, Cotter MA, Cameron NE: Nerve function and regeneration in diabetic and galactosemic rats: antioxidant and metal chelator effects. Eur J Pharmacol 314:33-39, 1996
43. Lambourne JE, Brown AM, Calcutt N, Tomlinson DR, Willars GB: Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosemia effects of aldose reductase inhibition. Diabetologia 31:379-384, 1988
44. +)-ATPase activity in galactose intoxication. Metabolism 40:1207-1212, 1991
45. Yonemura D, Aoki T, Tsuzuki K: Electroretinogram in diabetic retinopathy. Arch Ophthalmol 68:49-54, 1962
46. Algver P: Clinical studies on the oscillatory potentials of the human electroretinogram with special reference to the scotopic b-wave. Acta Ophthalmol 46:993-1024, 1968
47. Hofmann J: The potential for isoenzyme-selective modulation of protein kinase C. FASEB J 11:649-669, 1997
48. Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Komori H, Sakamoto N: Effect of niceritrol on streptozotocin-induced diabetic neuropathy in rats. Diabetes 41:587-591, 1992